BLOCK LISTING SIX MONTHLY RETURN
November 24, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG)
Name of applicant: Shire plc
Name of scheme: 2000 Executive Share Option Scheme
Period of return: From: May 23, 2014 To: November 22, 2014
Balance of unallotted securities under 3,406,623
scheme(s) from previous return:
Plus: The amount by which the block Nil
scheme(s) has been increased since the
date of the last return (if any
increase has been applied for):
Less: Number of securities issued/ Nil
allotted under scheme(s) during period
(see LR3.5.7G):
Equals: Balance under scheme(s) not 3,406,623
yet issued/allotted at end of period:
Name of applicant: Shire plc
Name of scheme: Shire Sharesave Scheme
Period of return: From: May 23, 2014 To: November 22, 2014
Balance of unallotted securities under 210,392
scheme(s) from previous return:
Plus: The amount by which the block Nil
scheme(s) has been increased since the
date of the last return (if any
increase has been applied for):
Less: Number of securities issued/ 2,634
allotted under scheme(s) during period
(see LR3.5.7G):
Equals: Balance under scheme(s) not 207,758
yet issued/allotted at end of period:
Name of applicant: Shire plc
Name of scheme: Portfolio Share Plan
Period of return: From: May 23, 2014 To: November 22, 2014
Balance of unallotted securities under 1,594,259
scheme(s) from previous return:
Plus: The amount by which the block Nil
scheme(s) has been increased since the
date of the last return (if any
increase has been applied for):
Less: Number of securities issued/ 456,045
allotted under scheme(s) during period
(see LR3.5.7G):
Equals: Balance under scheme(s) not 1,138,214
yet issued/allotted at end of period:
Name of applicant: Shire plc
Name of scheme: Employee Stock Purchase Plan
Period of return: From: May 23, 2014 To: November 22, 2014
Balance of unallotted securities under 422,301
scheme(s) from previous return:
Plus: The amount by which the block 500,000
scheme(s) has been increased since the
date of the last return (if any
increase has been applied for):
Less: Number of securities issued/ 397,591
allotted under scheme(s) during period
(see LR3.5.7G):
Equals: Balance under scheme(s) not 524,710
yet issued/allotted at end of period:
Name of contact: Tony Guthrie, Deputy Company Secretary
Address of contact: Hampshire International Business Park
Basingstoke, Hampshire, RG24 8EP
Telephone number of contact: 01256 894746
For further information please contact:
Investor Relations
Jeff Poulton jpoulton@shire.com +1 781 482 0945
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We focus on providing treatments in Neuroscience, Rare Diseases,
Gastrointestinal, and Internal Medicine and we are developing treatments for
symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas, such as Ophthalmology.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
Press Release
www.shire.com